Medicare Enrolled

Dr. Amy Kemmerlin, NP

Nurse Practitioner - Family · Charlotte, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
330 BILLINGSLEY RD STE 100, Charlotte, NC 28211
7044053953
In practice since 2021 (5 years)
NPI: 1891389656 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kemmerlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kemmerlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kemmerlin

Dr. Amy Kemmerlin is a nurse practitioner - family in Charlotte, NC, with 5 years of NPI registration. Based on federal Medicare data, Dr. Kemmerlin performed 214 Medicare services across 149 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kemmerlin received a total of $6,922 from 68 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kemmerlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice ▲ 214 Medicare services $6,922 industry payments

Medicare Practice Summary

Medicare Utilization ↗
214
Medicare services
Bottom 46% in NC for nurse practitioner - family
149
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
63 $7 $20
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
57 $93 $220
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
47 $7 $13
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
18 $11 $40
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
16 $96 $268
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
13 $10 $38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
14.5% medium
78.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,922
Total received (2021-2024)
Avg $1,731/year across 4 years
Top 3% in NC for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,063 (87.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$859 (12.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,595
2023
$1,936
2022
$1,535
2021
$856

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$215
PFIZER INC.
$189
ABBVIE INC.
$158
Astellas Pharma US Inc
$157
Takeda Pharmaceuticals U.S.A., Inc.
$146
Stemline Therapeutics Inc.
$109
AstraZeneca Pharmaceuticals LP
$109
Karyopharm Therapeutics Inc.
$102
Alexion Pharmaceuticals, Inc.
$97
Merck Sharp & Dohme LLC
$87
ARRAY BIOPHARMA INC
$81
Eisai Inc.
$77
Janssen Biotech, Inc.
$71
TAIHO ONCOLOGY, INC.
$60
Pharmacosmos Therapeutics Inc.
$60
Genentech USA, Inc.
$58
Genmab U.S., Inc.
$54
SERVIER PHARMACEUTICALS LLC
$47
Amneal Pharmaceuticals LLC
$47
JAZZ PHARMACEUTICALS INC.
$45
Celgene Corporation
$45
Aveo Pharmaceuticals, Inc.
$38
Exelixis Inc.
$34
ADC Therapeutics America, Inc.
$33
Fresenius Kabi USA, LLC
$30
GENZYME CORPORATION
$29
Deciphera Pharmaceuticals Inc.
$29
E.R. Squibb & Sons, L.L.C.
$29
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$25
Alnylam Pharmaceuticals Inc.
$24
Acrotech Biopharma Inc.
$24
GlaxoSmithKline, LLC.
$23
Lilly USA, LLC
$22
ACCORD HEALTHCARE, INC.
$22
Daiichi Sankyo Inc.
$22
Regeneron Healthcare Solutions, Inc.
$21
Gilead Sciences, Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Incyte Corporation
$18
SOBI, INC
$18
Coherus Biosciences Inc.
$18
Amgen Inc.
$16
Bard Peripheral Vascular, Inc.
$14
Adaptive Biotechnologies Corporation
$14
Rigel Pharmaceuticals, Inc.
$14
Top 3 companies account for 21.6% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$525
Novartis Pharmaceuticals Corporation
$354
Astellas Pharma US Inc
$320
PFIZER INC.
$313
Janssen Biotech, Inc.
$270
Incyte Corporation
$233
Merck Sharp & Dohme LLC
$230
Stemline Therapeutics Inc.
$219
Takeda Pharmaceuticals U.S.A., Inc.
$219
Daiichi Sankyo Inc.
$192
Alexion Pharmaceuticals, Inc.
$188
E.R. Squibb & Sons, L.L.C.
$184
Amgen Inc.
$171
ABBVIE INC.
$169
Novocure Inc.
$161
AVEO Pharmaceuticals, Inc.
$143
Eisai Inc.
$137
Pharmacosmos Therapeutics Inc.
$132
Exelixis Inc.
$129
Puma Biotechnology, Inc.
$110
JAZZ PHARMACEUTICALS INC.
$109
Global Blood Therapeutics, Inc.
$108
Genentech USA, Inc.
$102
Karyopharm Therapeutics Inc.
$102
ARRAY BIOPHARMA INC
$97
EISAI INC.
$88
Mirati Therapeutics, Inc.
$88
SANOFI-AVENTIS U.S. LLC
$87
Celgene Corporation
$83
GENZYME CORPORATION
$82
GlaxoSmithKline, LLC.
$80
TAIHO ONCOLOGY, INC.
$79
Regeneron Healthcare Solutions, Inc.
$79
Coherus Biosciences Inc.
$75
SERVIER PHARMACEUTICALS LLC
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
BeiGene USA, Inc.
$62
Lilly USA, LLC
$61
Aveo Pharmaceuticals, Inc.
$57
Genmab U.S., Inc.
$54
MorphoSys, US Inc.
$52
ADC Therapeutics America, Inc.
$51
Deciphera Pharmaceuticals Inc.
$49
Amneal Pharmaceuticals LLC
$47
Seagen Inc.
$45
Acrotech Biopharma Inc.
$45
ACCORD HEALTHCARE, INC.
$43
Alnylam Pharmaceuticals Inc.
$41
Pharmacyclics LLC, an AbbVie Company
$41
TerSera Therapeutics LLC
$39
Spectrum Pharmaceuticals Inc.
$39
Janssen Pharmaceuticals, Inc
$38
Gilead Sciences, Inc.
$36
NOVARTIS PHARMACEUTICALS CORPORATION
$35
Rigel Pharmaceuticals, Inc.
$31
Fresenius Kabi USA, LLC
$30
RECORDATI_RARE_DISEASES_INC.
$28
Pharmacyclics LLC, An AbbVie Company
$27
Bayer Healthcare Pharmaceuticals Inc.
$25
Epizyme, Inc.,
$22
Agios Pharmaceuticals, Inc.
$22
CTI BioPharma Corp.
$21
Genentech, Inc.
$18
SOBI, INC
$18
Kyowa Kirin, Inc.
$17
Bard Peripheral Vascular, Inc.
$14
Adaptive Biotechnologies Corporation
$14
Shield Therapeutics Inc
$13
Top 3 companies account for 17.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALUNBRIG · AVASTIN · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · CREON · Cabometyx · Columvi · DARZALEX · ELAHERE · ELITEK · ENHERTU · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · Monoferric · NINLARO · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OXBRYTA · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PYRUKYND · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · Rezlidhia · SARCLISA · SCEMBLIX · SYLVANT · Stimufend · TABRECTA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tibsovo · Tivdak · Trek · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for nurse practitioner - family in NC.

Looking for a nurse practitioner - family in Charlotte?
Compare family nurse practitioners in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
1,037
Per 100K population
91.7
County median income
$83,765
Nearest hospital
ATRIUM HEALTH PINEVILLE
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kemmerlin is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 3% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kemmerlin experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Kemmerlin performed 63 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kemmerlin receive payments from pharmaceutical companies?
Yes. Dr. Kemmerlin received a total of $6,922 from 68 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kemmerlin's costs compare to other family nurse practitioners in Charlotte?
Dr. Kemmerlin's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kemmerlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →